C260-2834 Screening compound: 2-{3-[2-(3,4-dimethoxyphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-methyl-N-phenylacetamide

C260-2834 Screening compound: 2-{3-[2-(3,4-dimethoxyphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-methyl-N-phenylacetamide
C260-2834 Screening compound: 2-{3-[2-(3,4-dimethoxyphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-methyl-N-phenylacetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound C260-2834
2-{3-[2-(3,4-dimethoxyphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-methyl-N-phenylacetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

C260-2834

Molecular Formula

C27H27N3O5 (C27 H27 N3 O5)

Compound Name

2-{3-[2-(3,4-dimethoxyphenyl)ethyl]-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-1-yl}-N-methyl-N-phenylacetamide

IUPAC name

2-{3-[2-(34-dimethoxyphenyl)ethyl]-24-dioxo-1234-tetrahydroquinazolin-1-yl}-N-methyl-N-phenylacetamide

SMILES

CN(C(CN(c(cccc1)c1C(N1CCc(cc2)cc(OC)c2OC)=O)C1=O)=O)c1ccccc1

InChI

InChI=1S/C27H27N3O5/c1-28(20-9-5-4-6-10-20)25(31)18-30-22-12-8-7-11-21(22)26(32)29(27(30)33)16-15-19-13-14-23(34-2)24(17-19)35-3/h4-14,17H,15-16,18H2,1-3H3

InChI Key

PIXFWDKHLDMAFN-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14738930

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.53

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

2.566

Distribution Coefficient, logD

2.566

Water Solubility, LogSw

-3.14

Polar Surface Area

61.619

Acid Dissociation Constant (pKa)

21.42

Base Dissociation Constant (pKb)

-0.31

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

22.20

C260-2834 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with C260-2834 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C260-2834?
Check Price and Availability of C260-2834, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C260-2834 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C260-2834
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C260-2834
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C260-2834 available by request